tm
Seeing Is Believing
tm
Seeing Is Believing
BOLD is currently covered by 1 analysts
Audentes Therapeutics's activity chart (see below) currently has 3 price targets and 3 ratings on display. The stock rating distribution of BOLD is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 6.67% with an average time for these price targets to be met of 10.8 days.
Highest price target for BOLD is $1, Lowest price target is $1.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 24-Oct-2025.
Currently out of the existing stock ratings of BOLD, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Jun-2025
$4
$1.66 (70.94%)
$4
1 years ago
(24-Oct-2025)
0/3 (0%)
$2.54 (173.97%)
Hold Since 28-May-2025
$3
$1.89 (170.27%)
$25
1 years 4 months 25 days ago
(28-May-2025)
0/2 (0%)
$1.8 (150.00%)
Buy Since 04-Dec-2019
$60
$58.87 (5209.73%)
$48
6 years 10 months 20 days ago
(04-Dec-2019)
0/4 (0%)
$60 (0.00%)
Buy Since 04-Dec-2019
$50
6 years 10 months 20 days ago
(04-Dec-2019)
0/3 (0%)
$50 (0.00%)
Hold Since 03-Dec-2019
$46
6 years 10 months 20 days ago
(03-Dec-2019)
0/1 (0%)
$46 (0.00%)
What is BOLD (Audentes Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on BOLD (Audentes Therapeutics)?
Which analyst has the most public recommendations on BOLD (Audentes Therapeutics)?
Which analyst is the currently most bullish on BOLD (Audentes Therapeutics)?
Which analyst is the currently most reserved on BOLD (Audentes Therapeutics)?
